ProMIS Neurosciences Inc.
1920 Yonge Street
Suite 200
Toronto, ON M4S 3E2
Canada
416-847-6898
http://www.amorfix.com
ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops therapeutics and diagnostics for the treatment of neurodegenerative diseases in Canada. It develops technology for treatment of Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's disease (AD). The company has strategic alliances with Epitomics Inc. to develop murine monoclonal antibodies; and license agreement with Biogen Idec for developing therapeutics to treat ALS. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences Inc. in July 2015. ProMIS Neurosciences Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.